Trials / Unknown
UnknownNCT03581058
Neural Correlates of Driving and Cannabis
Investigating the Neural Correlates of Driving After Medical Cannabis Exposure
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Unity Health Toronto · Academic / Other
- Sex
- All
- Age
- 25 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
Driving is a set of complex tasks and requires use of multiple cognitive domains, including attention, planning, and memory. In laboratory studies, the main psychoactive component in cannabis, delta-9-tetrahydrocannabinol (THC), was shown to impair short-term memory, attention, reaction time, tracking, and coordination, resulting, for instance, in significantly more deviations from the lane and increased break latency. Surveys and epidemiological studies suggest that cannabis consumption is associated with increased risks of collision. The current study aims to evaluate individual driving behavior and performance on various neurocognitive tests and their correlated neural networks while under the influence of cannabis and while sober. The investigators will use the STISIM driving simulator, which is fully MRI compatible, to study brain activation, while participants are performing various driving maneuvers. The goals of the study are: 1. identify driving performance and patterns in brain activation associated with cannabis exposure and compare them to brain patterns of the same participants while sober; 2. compare participant's performance on cognitive tasks while under the influence of cannabis and sober; 3. look for correlations between concentration of cannabinoids in the participants' blood and their driving performance and performance on cognitive tasks; 4. correlate demographic variables and personal history (e.g. tolerance to drug) with performance and brain activation while driving under the influence of cannabis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabis | Participants will be assigned to consume one of the cannabis strains and will complete testing immediately after consumption. |
Timeline
- Start date
- 2018-08-08
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2018-07-10
- Last updated
- 2020-03-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03581058. Inclusion in this directory is not an endorsement.